Facebook
Twitter
LinkedIn
ForwardSHY:Overview of the Treatment of Common Bleeding Disorders: Emphasis on On-demand Treatment with Coagulation Factor Replacement Products
Subjects will vary for each presentation within the series. In general, each presentation will review current pharmacotherapeutic management recommendation for a given disease state. The goal of the series is to ensure that our pharmacists practice consistent, evidence-based pharmacy.
ACPE: 0481-0000-19-097-L04-P
Target Audience
The target audience consists of pharmacists, pharmacy residents, and pharmacy students
Learning Objectives
- Offer structured support of professional development for pharmacists
- Incentivize pharmacists to engage in professional development sessions by providing continuing education credit for attendance
- Review current pharmacotherapeutic management recommendations for various disease states
- Emphasize knowledge gained during presentations through summary slides, questions and/or patient cases
- Ensure that residency preceptors are aware of current evidence-based pharmacy recommendations
- Describe the similarities and differences in treatment methodology in Hemophilia A, Hemophilia B, and von Willebrand Disease
- Explain how dosing is determined for on-demand treatment in Hemophilia A, Hemophilia B, and von Willebrand Disease
- Calculate on-demand dosing for Hemophilia A, Hemophilia B, and von Willebrand Disease.
- Describe the major differences in available coagulation factor replacement products for Hemophilia A, Hemophilia B, and von Willebrand Disease.
Additional Information
| Attachment | Size |
|---|---|
 COI Ballard 5.23.19.pdf | 239.13 KB |
| COI Hebda 5.23.19.pdf | 244.21 KB |
| Curriculum Vitae -Michele Hebda 2019.pdf | 477.7 KB |
| SLBallard CV 2.18.2018.pdf | 199.68 KB |
 Flyer.doc | 84.5 KB |
Subjects will vary for each presentation within the series. In general, each presentation will review current pharmacotherapeutic management recommendation for a given disease state. The goal of the series is to ensure that our pharmacists practice consistent, evidence-based pharmacy.
Selleca Huhn
The University of Pittsburgh Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.
The assigned universal program number(s) is: 0481-0000-19-097-L04-P
Available Credit
- 0.50 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.